Yang, C.-F., Wang, H., Kumar, A., Hartwig, M. G., D’Amico, T. A., Harpole, D., & Berry, M. F. (2016). Optimal timing of lobectomy for clinical stage IA non-small cell lung cancer. In Journal of Clinical Oncology (Vol. 34, pp. 8549–8549). American Society of Clinical Oncology (ASCO). https://doi.org/10.1200/jco.2016.34.15_suppl.8549

Yang, Chi-Fu Jeffrey, Hanghang Wang, Arvind Kumar, Matthew G. Hartwig, Thomas A. D’Amico, David Harpole, and Mark F. Berry. “Optimal timing of lobectomy for clinical stage IA non-small cell lung cancer.” In Journal of Clinical Oncology, 34:8549–8549. American Society of Clinical Oncology (ASCO), 2016. https://doi.org/10.1200/jco.2016.34.15_suppl.8549.

Yang C-FJ, Wang H, Kumar A, Hartwig MG, D’Amico TA, Harpole D, et al. Optimal timing of lobectomy for clinical stage IA non-small cell lung cancer. In: Journal of Clinical Oncology. American Society of Clinical Oncology (ASCO); 2016. p. 8549–8549.

Yang, Chi-Fu Jeffrey, et al. “Optimal timing of lobectomy for clinical stage IA non-small cell lung cancer.” Journal of Clinical Oncology, vol. 34, no. 15_suppl, American Society of Clinical Oncology (ASCO), 2016, pp. 8549–8549. Crossref, doi:10.1200/jco.2016.34.15_suppl.8549.

Yang C-FJ, Wang H, Kumar A, Hartwig MG, D’Amico TA, Harpole D, Berry MF. Optimal timing of lobectomy for clinical stage IA non-small cell lung cancer. Journal of Clinical Oncology. American Society of Clinical Oncology (ASCO); 2016. p. 8549–8549.